R REGENERON PHARMACEUTICALS INC: directors' dealings · United States · SEC (Form 4) Explore the full insider trade history of REGENERON PHARMACEUTICALS INC, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €65.6bn. The latest transaction was reported on 14 January 2016 (Acquisition). Among the most active insiders: Sanofi. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 14 January 2016
All Executives20 Thresholds0 Prospectus0 Other0
Declarations 20 total
▲ 10% Owner · Executives · 12 Jan 2016
5,007 shares Common Stock SEC:0001140361-16-047842:0
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
2,407 shares Common Stock SEC:0001140361-16-047842:1
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
2,164 shares Common Stock SEC:0001140361-16-047842:2
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
3,220 shares Common Stock SEC:0001140361-16-047842:3
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
3,100 shares Common Stock SEC:0001140361-16-047842:4
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
2,500 shares Common Stock SEC:0001140361-16-047842:5
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
3,563 shares Common Stock SEC:0001140361-16-047842:6
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
4,941 shares Common Stock SEC:0001140361-16-047842:7
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
2,759 shares Common Stock SEC:0001140361-16-047842:8
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
4,148 shares Common Stock SEC:0001140361-16-047842:9
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
8,002 shares Common Stock SEC:0001140361-16-047842:10
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
3,608 shares Common Stock SEC:0001140361-16-047842:11
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
4,901 shares Common Stock SEC:0001140361-16-047842:12
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
5,082 shares Common Stock SEC:0001140361-16-047842:13
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
7,204 shares Common Stock SEC:0001140361-16-047842:15
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
3,600 shares Common Stock SEC:0001140361-16-047842:16
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
3,563 shares Common Stock SEC:0001140361-16-047842:17
Ideal exit: 8 Oct 2016 (T+270) ▲ 10% Owner · Executives · 12 Jan 2016
14,169 shares Common Stock SEC:0001140361-16-047842:14
Ideal exit: 8 Oct 2016 (T+270) ● Director · Executives · 5 Nov 2015
1,000 shares Common Stock SEC:0001237899-16-000075:0
● Director · Executives · 5 Nov 2015
6,000 shares Common Stock SEC:0001237899-16-000073:0